Bharat Parenterals Limited (BPLPHARMA)

BSE: ₹1,380.00
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 69.91 59.81 58.80 65.64 92.06 64.45 67.34 80.28 94.37 41.70 41.41 56.54
YOY Revenue Growth % 167.96% -26.97% -0.37% 28.78% 31.68% 7.76% 14.52% 22.3% 2.51% -35.3% -38.5% -29.58%
Other Income 2.86 3.46 2.40 3.24 3.90 4.60 3.79 2.26 1.62 4.21 2.28 4.44
Total Income 72.77 63.27 61.20 68.88 95.96 69.05 71.13 82.54 95.99 45.91 43.69 60.98
Total Expenses + 60.81 55.60 54.30 64.60 79.70 61.42 62.26 78.98 82.59 42.49 40.59 59.06
Cost of Materials Consumed 46.13 29.61 49.61 47.81 54.80 26.93 45.25 51.35 54.83 31.28 20.82 41.97
Employee Benefit Expense 4.24 4.72 4.90 5.75 4.99 5.42 5.29 5.67 5.96 6.51 6.52 6.14
Other Expenses 13.71 11.44 10.56 12.01 17.23 11.68 15.52 15.12 10.32 9.54 6.30 9.67
Operating Profit 9.10 4.21 4.50 1.04 12.36 3.03 5.08 1.30 11.78 -0.79 0.82 -2.52
OPM % 13% 7% 7.7% 1.6% 13.4% 4.7% 7.5% 1.6% 12.5% -1.9% 2% -4.5%
Profit Before Tax + 11.96 7.67 6.90 4.28 16.26 7.63 8.87 3.56 13.40 3.42 3.10 1.93
Tax Expense 11.96 2.11 1.83 1.21 4.08 2.14 2.37 1.28 3.40 0.69 1.18 0.55
Tax % 100% 27.5% 26.5% 28.3% 25.1% 28% 26.7% 36% 25.4% 20.2% 38.2% 28.5%
Profit After Tax 0.00 5.56 5.07 3.07 12.18 5.49 6.50 2.28 10.00 2.73 1.92 1.38
EPS (Basic) 15.40 9.62 8.65 5.15 20.26 7.90 8.30 3.48 14.51 3.96 2.78 2.00

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 234.01 304.13 254.16 217.98 212.01 203.67
YOY Revenue Growth % -23.05% 19.66% 16.6% 2.82% 4.09% -
Other Income 12.55 14.56 11.96 18.84 7.78 8.67
Total Income 246.57 318.69 266.12 236.82 219.79 212.34
Total Expenses + 224.72 282.37 235.32 204.65 191.42 185.32
Cost of Materials Consumed 148.90 178.34 173.16 146.07 132.72 127.13
Employee Benefit Expense 25.13 21.38 19.61 16.93 15.26 14.39
Other Expenses 35.84 59.54 47.73 42.20 32.55 30.11
Operating Profit 9.29 21.76 18.84 13.33 20.59 18.35
OPM % 4% 7.2% 7.4% 6.1% 9.7% 9%
Profit Before Exceptional 21.84 36.32 30.80 32.17 28.37 27.02
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 21.84 36.32 30.80 32.17 28.37 27.02
Tax Expense 5.82 9.87 8.21 7.83 7.07 6.81
Tax % 26.7% 27.2% 26.7% 24.3% 24.9% 25.2%
Profit After Tax 16.02 26.45 22.59 24.34 21.30 20.21
EPS (Basic) 23.24 40.36 8.65 42.40 37.11 35.27

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 299.77 283.41 168.99 133.52 74.64 49.21
Property, Plant & Equipment 49.80 45.37 38.46 35.28 39.75 43.36
Capital Work in Progress 5.52 5.00 0.00 0.00 0.62 0.00
Non-Current Investments 194.60 167.80 48.61 38.40 4.82 0.03
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 220.17 265.78 218.16 174.51 143.36 147.03
Inventories 54.33 46.85 54.43 37.84 20.76 22.43
Trade Receivables 120.57 164.72 139.78 112.40 73.40 67.83
Cash and Cash Equivalents 0.52 0.34 1.43 6.35 3.33 1.40
Current Investments 0.00 0.00 0.00 0.00 11.48 41.79
LIABILITIES & EQUITY
Total Equity 402.34 386.82 213.61 191.06 166.15 143.94
Equity Share Capital 6.89 6.89 5.82 5.77 5.77 5.73
Other Equity 395.45 379.93 207.79 185.29 160.38 138.21
Non-Current Liabilities 15.73 7.74 5.76 8.62 11.64 11.20
Current Liabilities 101.87 154.63 167.78 108.35 40.21 41.10
Total Liabilities 117.60 162.37 173.54 116.97 51.85 52.30

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities 44.57 47.67 -22.91 -11.56 -22.15 29.67
Cash from Investing Activities 4.14 89.70 -16.10 -13.95 21.76 -46.27
Cash from Financing Activities -48.80 69.25 34.17 28.52 2.32 8.31
Net Increase/Decrease in Cash -0.10 205.41 -4.83 3.00 1.93 -8.29